NewGenIvf Group (NIVF) Competitors

$1.46 -0.23 (-13.61%)

Closing price 04:00 PM Eastern

Extended Trading

$1.42 -0.04 (-3.08%)

As of 07:58 PM Eastern

NIVF vs. DHAC, BACK, BTTX, UPHL, and ACONW

Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Digital Health Acquisition (DHAC), IMAC (BACK), Better Therapeutics (BTTX), UpHealth (UPHL), and Aclarion (ACONW). These companies are all part of the "healthcare" industry.

How does NewGenIvf Group compare to Digital Health Acquisition?

Digital Health Acquisition (NASDAQ:DHAC) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.

: Company Net Margins Return on Equity Return on Assets
Digital Health Acquisition N/A N/A N/A
NewGenIvf Group N/A N/A N/A
: 1.0% of Digital Health Acquisition shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 6.6% of Digital Health Acquisition shares are owned by insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digital Health Acquisition
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
NewGenIvf Group
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: In the previous week, NewGenIvf Group had 2 more articles in the media than Digital Health Acquisition. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for Digital Health Acquisition. Digital Health Acquisition's average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.23 indicating that Digital Health Acquisition is being referred to more favorably in the media.
Company Overall Sentiment
Digital Health Acquisition Neutral
NewGenIvf Group Neutral
: NewGenIvf Group has higher revenue and earnings than Digital Health Acquisition.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Digital Health Acquisition N/A N/A N/A N/A N/A
NewGenIvf Group $4.73M 0.08 $9.88M N/A N/A
: Digital Health Acquisition has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500.

Company	Net Margins	Return on Equity	Return on Assets
Digital Health Acquisition	N/A	N/A	N/A
NewGenIvf Group	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Digital Health Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Overall Sentiment
Digital Health Acquisition	Neutral
NewGenIvf Group	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Digital Health Acquisition	N/A	N/A	N/A	N/A	N/A
NewGenIvf Group	$4.73M	0.08	$9.88M	N/A	N/A

Summary

NewGenIvf Group beats Digital Health Acquisition on 5 of the 7 factors compared between the two stocks.

How does NewGenIvf Group compare to IMAC?

IMAC (NASDAQ:BACK) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

: In the previous week, NewGenIvf Group had 2 more articles in the media than IMAC. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for IMAC. IMAC's average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.23 indicating that IMAC is being referred to more favorably in the media.
Company Overall Sentiment
IMAC Neutral
NewGenIvf Group Neutral
: 5.8% of IMAC shares are held by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are held by institutional investors. 12.3% of IMAC shares are held by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
: NewGenIvf Group has higher revenue and earnings than IMAC.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IMAC $72.05K 2.05 -$9.42M -$3.12 N/A
NewGenIvf Group $4.73M 0.08 $9.88M N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IMAC
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
NewGenIvf Group
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Company Net Margins Return on Equity Return on Assets
IMAC N/A N/A -325.44%
NewGenIvf Group N/A N/A N/A
: IMAC has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500.

Company	Overall Sentiment
IMAC	Neutral
NewGenIvf Group	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMAC	$72.05K	2.05	-$9.42M	-$3.12	N/A
NewGenIvf Group	$4.73M	0.08	$9.88M	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IMAC	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
IMAC	N/A	N/A	-325.44%
NewGenIvf Group	N/A	N/A	N/A

Summary

NewGenIvf Group beats IMAC on 7 of the 10 factors compared between the two stocks.

How does NewGenIvf Group compare to Better Therapeutics?

NewGenIvf Group (NASDAQ:NIVF) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

: In the previous week, NewGenIvf Group had 2 more articles in the media than Better Therapeutics. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for Better Therapeutics. Better Therapeutics' average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.23 indicating that Better Therapeutics is being referred to more favorably in the news media.
Company Overall Sentiment
NewGenIvf Group Neutral
Better Therapeutics Neutral
: 66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by company insiders. Comparatively, 51.4% of Better Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
: NewGenIvf Group has higher revenue and earnings than Better Therapeutics.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NewGenIvf Group $4.73M 0.08 $9.88M N/A N/A
Better Therapeutics N/A N/A -$39.76M -$0.78 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NewGenIvf Group
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Better Therapeutics
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Company Net Margins Return on Equity Return on Assets
NewGenIvf Group N/A N/A N/A
Better Therapeutics N/A N/A N/A
: NewGenIvf Group has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500.

Company	Overall Sentiment
NewGenIvf Group	Neutral
Better Therapeutics	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$4.73M	0.08	$9.88M	N/A	N/A
Better Therapeutics	N/A	N/A	-$39.76M	-$0.78	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Better Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
Better Therapeutics	N/A	N/A	N/A

Summary

NewGenIvf Group beats Better Therapeutics on 5 of the 8 factors compared between the two stocks.

How does NewGenIvf Group compare to UpHealth?

NewGenIvf Group (NASDAQ:NIVF) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

: Given UpHealth's higher probable upside, analysts clearly believe UpHealth is more favorable than NewGenIvf Group.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NewGenIvf Group
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
UpHealth
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
: Company Net Margins Return on Equity Return on Assets
NewGenIvf Group N/A N/A N/A
UpHealth N/A N/A N/A
: 66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 56.1% of UpHealth shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by company insiders. Comparatively, 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
: NewGenIvf Group has higher earnings, but lower revenue than UpHealth.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
NewGenIvf Group $4.73M 0.08 $9.88M N/A N/A
UpHealth $130M 0.00 -$56.42M $1.47 N/A
: In the previous week, NewGenIvf Group had 2 more articles in the media than UpHealth. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for UpHealth. UpHealth's average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.23 indicating that UpHealth is being referred to more favorably in the news media.
Company Overall Sentiment
NewGenIvf Group Neutral
UpHealth Neutral
: NewGenIvf Group has a beta of 0.04, indicating that its share price is 96% less volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
UpHealth	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Company	Net Margins	Return on Equity	Return on Assets
NewGenIvf Group	N/A	N/A	N/A
UpHealth	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NewGenIvf Group	$4.73M	0.08	$9.88M	N/A	N/A
UpHealth	$130M	0.00	-$56.42M	$1.47	N/A

Company	Overall Sentiment
NewGenIvf Group	Neutral
UpHealth	Neutral

Summary

UpHealth beats NewGenIvf Group on 5 of the 9 factors compared between the two stocks.

How does NewGenIvf Group compare to Aclarion?

Aclarion (NASDAQ:ACONW) and NewGenIvf Group (NASDAQ:NIVF) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aclarion
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
NewGenIvf Group
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Company Net Margins Return on Equity Return on Assets
Aclarion N/A N/A N/A
NewGenIvf Group N/A N/A N/A
: 66.2% of NewGenIvf Group shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: NewGenIvf Group has higher revenue and earnings than Aclarion.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Aclarion $75.73K N/A N/A N/A N/A
NewGenIvf Group $4.73M 0.08 $9.88M N/A N/A
: In the previous week, NewGenIvf Group had 2 more articles in the media than Aclarion. MarketBeat recorded 2 mentions for NewGenIvf Group and 0 mentions for Aclarion. Aclarion's average media sentiment score of 0.00 beat NewGenIvf Group's score of -0.23 indicating that Aclarion is being referred to more favorably in the media.
Company Overall Sentiment
Aclarion Neutral
NewGenIvf Group Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
NewGenIvf Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	N/A	N/A	N/A
NewGenIvf Group	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$75.73K	N/A	N/A	N/A	N/A
NewGenIvf Group	$4.73M	0.08	$9.88M	N/A	N/A

Company	Overall Sentiment
Aclarion	Neutral
NewGenIvf Group	Neutral

Summary

NewGenIvf Group beats Aclarion on 5 of the 6 factors compared between the two stocks.

Get NewGenIvf Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NIVF vs. The Competition

Export

Metric	NewGenIvf Group	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$420K	$8.12B	$6.25B	$11.77B
Dividend Yield	N/A	2.19%	2.74%	5.26%
P/E Ratio	N/A	24.84	29.25	27.07
Price / Sales	0.08	17.53	504.14	75.42
Price / Cash	0.04	82.65	43.30	53.90
Price / Book	0.01	4.81	9.67	6.69
Net Income	$9.88M	$183.43M	$3.55B	$332.64M
7 Day Performance	-23.16%	0.20%	1.70%	2.01%
1 Month Performance	-31.46%	5.27%	5.62%	9.19%
1 Year Performance	-99.86%	0.38%	34.42%	39.59%

NewGenIvf Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NIVF NewGenIvf Group	1.3653 of 5 stars	$1.46 -13.6%	N/A	N/A	$420K	$4.73M	N/A	N/A	News Coverage Positive News
DHAC Digital Health Acquisition	N/A	$0.19 -7.5%	N/A	N/A	$687K	N/A	N/A	2,021	High Trading Volume
BACK IMAC	N/A	$0.05 +17.6%	N/A	N/A	$208K	$72.05K	N/A	180	Gap Up
BTTX Better Therapeutics	N/A	$0.00 flat	N/A	N/A	$4K	N/A	N/A	40
UPHL UpHealth	N/A	$0.00 flat	N/A	N/A	$2K	$130M	N/A	1,750

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NIVF) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

NewGenIvf Group (NIVF) Competitors

NIVF vs. DHAC, BACK, BTTX, UPHL, and ACONW

How does NewGenIvf Group compare to Digital Health Acquisition?

Summary

How does NewGenIvf Group compare to IMAC?

Summary

How does NewGenIvf Group compare to Better Therapeutics?

Summary

How does NewGenIvf Group compare to UpHealth?

Summary

How does NewGenIvf Group compare to Aclarion?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NIVF vs. The Competition

NewGenIvf Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

NewGenIvf Group (NIVF) Competitors

NIVF vs. DHAC, BACK, BTTX, UPHL, and ACONW

How does NewGenIvf Group compare to Digital Health Acquisition?

Summary

How does NewGenIvf Group compare to IMAC?

Summary

How does NewGenIvf Group compare to Better Therapeutics?

Summary

How does NewGenIvf Group compare to UpHealth?

Summary

How does NewGenIvf Group compare to Aclarion?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NIVF vs. The Competition

NewGenIvf Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools